Atlas Trials

FOLFIRI Versus Docetaxel and Cisplatin as a Second-line Chemotherapy After Failure of First-line Chemotherapy in Advanced Gastric Cancer

Clinical trial NCT03067792 · COMPLETED

Trial details

NCT number
NCT03067792
Sponsor
Yonsei University
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Inoperable Gastric Cancer
Start date
2014-12-01
Primary completion
2016-10-17
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.